Polo like kinase 2 (PLK2), a member of the serine/threonine kinases family, could induce glioblastoma resistance to temozolomide by regulating Hes family BHLH transcription factor 1 (HES1) and notch signaling [30]. Here, HES1 is linked to glioblastoma.